Carmine N. Stengone, CEO and President: Contineum Therapeutics CTNM Sell · Filed 02/26

Trade details

Type: Insider sale
Amount: $43,254
Shares · price: 2,700 sh · $16.02 a share
Held after: 14,954 sh
Stock: Contineum Therapeutics CTNM
Person: Carmine N. StengoneCEO and President
Trade date: 26/02/25
Filed: 26/02/26
Days to filing: 1 days

Sold 15.3% of holdings

Share of holding sold: 15.3%

Contineum Therapeutics trades, last 26 weeks

What else happened in Contineum Therapeutics around then

Filed or reported within 30 days of the trade day · 01/26~03/27

Carmine N. Stengone's recent trades

Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$41.8K
2,500 sh
$41.8K
Filed 09/08
Traded 09/08
Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$38.7K
2,500 sh
$38.7K
Filed 08/03
Traded 08/03
Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$36.4K
2,500 sh
$36.4K
Filed 07/08
Traded 07/08
Carmine N. StengoneDirector, Officer
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$150K
10,000 sh
$150K
Filed 06/30
Traded 06/30
Carmine N. StengoneCEO and President
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$70.5K
4,400 sh
$70.5K
Filed 02/26
Traded 02/24

Carmine N. Stengone, CEO — sold $43.3K of Contineum Therapeutics CTNM · 15.3% of holdings · 10b5-1 plan | Whalegun